1 – 2 of 2 jobs
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Date Posted:2026-07-30 Country:United States of America Location:US-IN-FT WAYNE-150A ~ 1010 Production Rd ~ BLDG 150A Position Role Type:Hybrid U.S. Citizen, U.S. Person, or Immigration Status Requirements: The ability to obtain and maintain a U.S. government issued
Recommended jobs for you
